Development of new sensitivities
The development of new sensitivities which were not present before the illness or have worsened since is a common occurence in ME/CFS.
Symptom recognition[edit | edit source]
- The International Consensus Criteria lists sensitivities to food, medications, odours or chemicals as an optional criteria for diagnosis, under the section C. Immune, gastro-intestinal and genitourinary Impairments.
Types of sensitivities[edit | edit source]
Prevalence[edit | edit source]
- In a 2001 Belgian study, 48.5% of patients meeting the Fukuda criteria and 54.8% of patients meeting the Holmes criteria, in a cohort of 2073 CFS patients, reported new sensitivities to food or drugs.
References[edit | edit source]
- Carruthers, BM; van de Sande, MI; De Meirleir, KL; Klimas, NG; Broderick, G; Mitchell, T; Staines, D; Powles, ACP; Speight, N; Vallings, R; Bateman, L; Baumgarten-Austrheim, B; Bell, DS; Carlo-Stella, N; Chia, J; Darragh, A; Jo, D; Lewis, DP; Light, AR; Marshall-Gradisnik, S; Mena, I; Mikovits, JA; Miwa, K; Murovska, M; Pall, ML; Stevens, SR (22 August 2011), "Myalgic encephalomyelitis: International Consensus Criteria", Journal of Internal Medicine, 270 (4): 327–338, doi:10.1111/j.1365-2796.2011.02428.x, PMID 21777306
- De Becker, P; McGregor, N; De Meirleir, K (Sep 2001), "A definition-based analysis of symptoms in a large cohort of patients with chronic fatigue syndrome.", Journal of Internal Medicine, 250 (3): 234-240, PMID 11555128